Conditions
Pertussis
5 articles published between June 27, 2025 and October 18, 2026.
Covered in Global Health, Children & Family Health and Policy.
A case-control study of young children during a statewide whooping-cough outbreak found three or more DTaP doses cut the odds of pertussis by more than 25-fold against unvaccinated peers.
3 min read
ANALYSISNational surveillance recorded 60,826 cases in Japan by July 2025 — about 15 times the previous year's 4054 — concentrated in school-age children, while four other countries had already peaked and declined.
4 min read
THE DRUG DOCKETIn a 366-child phase 2b trial, the live attenuated nasal vaccine BPZE1 raised the mucosal antibody current shots miss, and did not blunt a co-given Tdap. The maker funded the study.
3 min read
ANALYSISEleven vaccines remain recommended for all children. The rest move to risk-based or shared-decision categories, on the strength of a comparison with 20 other countries.
4 min read
ANALYSISA Global Burden of Disease analysis of 204 countries finds 15.7 million children received no DTP dose in 2023, more than half of them in eight countries, and only one of three target vaccines on track for 2030.
4 min read
This page indexes this newspaper’s reporting on Pertussis. It is not a medical reference entry, and nothing here is medical advice. See our editorial standards.